Home > Financial Ratios > ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
EV/Core EBITDA

    Back to All Ratios
ASTRAZENECA PHARMA INDIA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ASTRAZENECA PHARMA INDIA
Please provide your vote to see the results

ASTRAZENECA PHARMA INDIA Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 71.2158.3639.8458.8548.37

What is the latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA ?

The latest EV/Core EBITDA ratio of ASTRAZENECA PHARMA INDIA is 71.21 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar202571.21
Mar202458.36
Mar202339.84
Mar202258.85
Mar202148.37

How is EV/Core EBITDA of ASTRAZENECA PHARMA INDIA Trending?

Years EV/Core EBITDA % Change
Mar2025 71.21
22.02
Mar2024 58.36
46.49
Mar2023 39.84
-32.30
Mar2022 58.85
21.67
Mar2021 48.37 -

Other Financial Ratios of ASTRAZENECA PHARMA INDIA


Compare EV/Core EBITDA ratio of peers of ASTRAZENECA PHARMA INDIA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA ₹22,383.4 Cr -4.6% 1.8% 44.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹403,712.0 Cr -1.2% 1.3% 5.7% Stock Analytics
DIVIS LABORATORIES ₹176,623.0 Cr -2% 1.3% 45.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,285.0 Cr 1.4% 11.9% 15.7% Stock Analytics
CIPLA ₹119,010.0 Cr -0.6% -2% -1.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,118.0 Cr -1.2% -6.7% -8.4% Stock Analytics


ASTRAZENECA PHARMA INDIA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ASTRAZENECA PHARMA INDIA

-4.6%

1.8%

44.2%

SENSEX

0.1%

1%

2.6%


You may also like the below Video Courses